TY - JOUR
T1 - Atrial fibrillation prevalence, awareness and management in a nationwide survey of adults in China
AU - Du, Xin
AU - Guo, Lizhu
AU - Xia, Shijun
AU - Du, Jing
AU - Anderson, Craig
AU - Arima, Hisatomi
AU - Huffman, Mark
AU - Yuan, Yiqiang
AU - Zheng, Yang
AU - Wu, Shulin
AU - Guang, Xuefeng
AU - Zhou, Xianhui
AU - Lin, Hongbo
AU - Cheng, Xiaoshu
AU - Dong, Jianzeng
AU - Ma, Changsheng
N1 - Publisher Copyright:
© 2021 The Author(s). Published by Cambridge University Press.
PY - 2021/4/1
Y1 - 2021/4/1
N2 - Objective To determine AF prevalence and gaps in atrial fibrillation (AF) awareness and management in China. Methods We conducted a community-based survey of 47 841 adults (age ≥45 years) in seven geographic regions of China between 2014 and 2016. Participants underwent a structured questionnaire, a standard 12-lead ECG, physical examination and blood sampling. AF prevalence, defined by either ECG detection or self-report, was estimated according to sampling weights, non-response and age and sex distribution of the population. We used multivariable logistic regression to estimate associations among sociodemographic, clinical and geographic factors with the AF prevalence, awareness and treatment. Results The weighted AF prevalence was 1.8% (95% CI 1.7% to 1.9%), but varied from 0.9% to 2.4% across geographical regions and equates to being present in an estimated 7.9 (95% CI 7.4 to 8.4) million people in China. Among men and women, the AF prevalence increased from 0.8% and 0.6% in the age group 45-54 years to 5.4% and 4.9% in the age group ≥75 years, respectively. Proportions of people who were aware of having AF decreased overall from 65.3% in 45-54 year-olds to 53.9% in ≥75 year-olds and varied between sex (men 58.5%, women 68.8%) and residency status (urban 78.3%, rural 35.3%). Only 6.0% of patients with high-risk AF received anticoagulation therapy. Conclusions AF prevalence is higher than previously reported in China, with low awareness and large treatment gaps. Large-scale efforts are urgently needed to reduce AF adverse consequences.
AB - Objective To determine AF prevalence and gaps in atrial fibrillation (AF) awareness and management in China. Methods We conducted a community-based survey of 47 841 adults (age ≥45 years) in seven geographic regions of China between 2014 and 2016. Participants underwent a structured questionnaire, a standard 12-lead ECG, physical examination and blood sampling. AF prevalence, defined by either ECG detection or self-report, was estimated according to sampling weights, non-response and age and sex distribution of the population. We used multivariable logistic regression to estimate associations among sociodemographic, clinical and geographic factors with the AF prevalence, awareness and treatment. Results The weighted AF prevalence was 1.8% (95% CI 1.7% to 1.9%), but varied from 0.9% to 2.4% across geographical regions and equates to being present in an estimated 7.9 (95% CI 7.4 to 8.4) million people in China. Among men and women, the AF prevalence increased from 0.8% and 0.6% in the age group 45-54 years to 5.4% and 4.9% in the age group ≥75 years, respectively. Proportions of people who were aware of having AF decreased overall from 65.3% in 45-54 year-olds to 53.9% in ≥75 year-olds and varied between sex (men 58.5%, women 68.8%) and residency status (urban 78.3%, rural 35.3%). Only 6.0% of patients with high-risk AF received anticoagulation therapy. Conclusions AF prevalence is higher than previously reported in China, with low awareness and large treatment gaps. Large-scale efforts are urgently needed to reduce AF adverse consequences.
KW - atrial fibrillation
KW - epidemiology
UR - http://www.scopus.com/inward/record.url?scp=85100287346&partnerID=8YFLogxK
U2 - 10.1136/heartjnl-2020-317915
DO - 10.1136/heartjnl-2020-317915
M3 - Article
C2 - 33509976
AN - SCOPUS:85100287346
SN - 1355-6037
VL - 107
SP - 535
EP - 541
JO - Heart
JF - Heart
IS - 7
ER -